Squarepoint
AGRX

Squarepoint’s Agile Therapeutics AGRX Stock Holding History

Squarepoint’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-16
Closed -$43K – 3656
2021
Q2 		$43K Buy
+16
New +$52.8K ﹤0.01% 3116
2021
Q1 		– Sell
-57
Closed -$330K – 3799
2020
Q4 		$330K Buy
+57
New +$336K ﹤0.01% 2135
2020
Q3 		– Sell
-19
Closed -$108K – 2963
2020
Q2 		$108K Buy
+19
New +$98.7K ﹤0.01% 1996
2019
Q4 		– Sell
-24
Closed -$57K – 2915
2019
Q3 		$57K Buy
+24
New +$59.1K ﹤0.01% 2232
2018
Q1 		– Sell
-12
Closed -$63K – 2285
2017
Q4 		$63K Sell
12
-6
-33% -$55.9K ﹤0.01% 1998
2017
Q3 		$158K Buy
+18
New +$138K ﹤0.01% 1445

Other funds holding AGRX

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return